Summary of the Centers for Disease Control and Prevention/National Institute of Allergy and Infectious Diseases Joint Workshop on Genital Herpes: 3–4 November 2022
Genital herpes is caused by infection with herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) and currently has no cure. The disease is the second-most common sexually transmitted infection in the United States, with an estimated 18.6 million prevalent genital infections caused by HSV-2 alone. Genital herpes diagnostics and treatments are not optimal, and no vaccine is currently available. The Centers for Disease Control and Prevention and the National Institute of Allergy and Infectious Diseases convened a workshop entitled “CDC/NIAID Joint Workshop on Genital Herpes.” This report summarizes 8 sessions on the epidemiology of genital herpes, neonatal HSV, HSV diagnostics, vaccines, treatments, cures, prevention, and patient advocacy perspective intended to identify opportunities in herpes research and foster the development of strategies to diagnose, treat, cure, and prevent genital herpes.
August 2024
Click for full info +Full Info:
Resource Type:
Journal Article
Journal Article
Resource
Citation:
Authors: Connolly, K.L.; Bachmann, L.; Hiltke, T.; Kersh, E.N.; Newman, L.M.; Wilson, L.; Mena, L.; Deal, C.
Health Risks(s):
- HSV
Topic(s):
- Advocacy
- Epidemiology
- Risk
Region(s)
- United States
- Global
Additional Keywords:
simplexvirus, hypersensitivity, genital herpes, centers for disease control and prevention (u.s.), communicable diseases, human herpesvirus 1, human herpesvirus 2, vaccines, infections, diagnosis, neonatal herpes, genital system, prevention